Hrt Financial LP Simulations Plus, Inc. Transaction History

Hrt Financial LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$40.45 - $48.0 $342,530 - $406,464	8,468 New	8,468 $366,000
Q2 2022 Aug 12, 2022	BUY	$40.55 - $51.76 $597,382 - $762,528	14,732 New	14,732 $726,000
Q4 2021 Feb 14, 2022	SELL	$37.1 - $57.45 $326,183 - $505,100	-8,792 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$38.45 - $55.66 $132,306 - $191,526	3,441 Added 64.31%	8,792 $347,000
Q2 2021 Aug 16, 2021	BUY	$49.67 - $68.96 $265,784 - $369,004	5,351 New	5,351 $293,000
Q1 2021 May 17, 2021	SELL	$60.06 - $89.52 $304,864 - $454,403	-5,076 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$53.26 - $77.18 $270,347 - $391,765	5,076 New	5,076 $365,000

175

15.1M

5.4K

1.4K

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $582M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.